(Reuters) – Teva Pharmaceuticals will pay a fine of $225 million over five years to settle the criminal price-fixing charges brought against Teva in 2020 by the U.S. Department of Justice, the company said on Monday.
(Reporting by Pratik Jain in Bengaluru; Editing by Shailesh Kuber)